Atherogenic Dyslipidemia and Atherogenic Index of Plasma in Sudanese Adults with Type 2 Diabetes Mellitus: A Case Control Study

Abstract Background The atherogenic index of plasma (AIP) is an inexpensive composite marker of atherogenic lipid risk that has emerged as a valuable tool in patients with type 2 diabetes mellitus (T2DM), a population which cardiovascular risk is driven substantially by atherogenic dyslipidemia. However case–control data quantifying AIP performance in Sudanese adults with T2DM are lacking. Objective To quantify the burden of atherogenic dyslipidemia and evaluate the diagnostic and independent predictive performance of AIP in Sudanese adults with T2DM relative to healthy controls. Methods In this case control study, 245 adults with T2DM and 245 age- and sex-matched healthy controls were recruited from three teaching hospitals in Al Jazirah State, Sudan. Anthropometric indices and a fasting lipid and glycemic profile were measured, and AIP was calculated as log₁₀(triglycerides/HDL-cholesterol). Group differences were assessed with the Mann-Whitney U and Chi-square tests, associations with Spearman correlation, diagnostic performance with ROC curve analysis, and independent predictors with binary logistic regression adjusting for BMI, waist–hip ratio, and age. Results Cases showed a fully atherogenic lipid profile relative to controls, including significantly higher AIP (median 0.778 vs. 0.497, p < 0.001). Among cases, AIP correlated strongly with VLDL-C (r = 0.638, p < 0.001) but not with FBG, HbA1c, insulin, or HOMA-IR. AIP discriminated cases from controls with good accuracy (AUC = 0.821, 95% CI: 0.784–0.857; optimal cutoff 0.654, sensitivity 75.1%, specificity 73.5%) and remained an independent predictor of T2DM status after adjustment for BMI, waist–hip ratio, and age (Wald = 64.53, p < 0.001; overall model accuracy 87.6%). Conclusion Sudanese adults with T2DM carry a substantially greater atherogenic lipid burden than healthy controls, and AIP is an independent, low-cost marker of this risk that is distinct from glycemic status. AIP may serve as a practical adjunct for cardiovascular risk stratification in resource-limited settings.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11000311/v1
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Atherogenic Dyslipidemia and Atherogenic Index of Plasma in Sudanese Adults with Type 2 Diabetes Mellitus: A Case Control Study

Abdelgadir Elmugadam, Abuagla M. Dafalla, Almoeiz Y Hammad, Ahmed A. Siragalnoor
Research Square
Diabetes, Cardiovascular Risks, and Lipoproteins
preprint

Atherogenic Dyslipidemia and Atherogenic Index of Plasma in Sudanese Adults with Type 2 Diabetes Mellitus: A Case Control Study

Abdelgadir Elmugadam, Abuagla M. Dafalla, Almoeiz Y Hammad, Ahmed A. Siragalnoor
preprint en

Abstract

Abstract Background The atherogenic index of plasma (AIP) is an inexpensive composite marker of atherogenic lipid risk that has emerged as a valuable tool in patients with type 2 diabetes mellitus (T2DM), a population which cardiovascular risk is driven substantially by atherogenic dyslipidemia. However case–control data quantifying AIP performance in Sudanese adults with T2DM are lacking. Objective To quantify the burden of atherogenic dyslipidemia and evaluate the diagnostic and independent predictive performance of AIP in Sudanese adults with T2DM relative to healthy controls. Methods In this case control study, 245 adults with T2DM and 245 age- and sex-matched healthy controls were recruited from three teaching hospitals in Al Jazirah State, Sudan. Anthropometric indices and a fasting lipid and glycemic profile were measured, and AIP was calculated as log₁₀(triglycerides/HDL-cholesterol). Group differences were assessed with the Mann-Whitney U and Chi-square tests, associations with Spearman correlation, diagnostic performance with ROC curve analysis, and independent predictors with binary logistic regression adjusting for BMI, waist–hip ratio, and age. Results Cases showed a fully atherogenic lipid profile relative to controls, including significantly higher AIP (median 0.778 vs. 0.497, p < 0.001). Among cases, AIP correlated strongly with VLDL-C (r = 0.638, p < 0.001) but not with FBG, HbA1c, insulin, or HOMA-IR. AIP discriminated cases from controls with good accuracy (AUC = 0.821, 95% CI: 0.784–0.857; optimal cutoff 0.654, sensitivity 75.1%, specificity 73.5%) and remained an independent predictor of T2DM status after adjustment for BMI, waist–hip ratio, and age (Wald = 64.53, p < 0.001; overall model accuracy 87.6%). Conclusion Sudanese adults with T2DM carry a substantially greater atherogenic lipid burden than healthy controls, and AIP is an independent, low-cost marker of this risk that is distinct from glycemic status. AIP may serve as a practical adjunct for cardiovascular risk stratification in resource-limited settings.

Research Square
Kampala International University (UG), University of Gezira (SD), Sudan University of Science and Technology (SD)
Good health and well-being
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon